Pharmaids Pharmaceuticals Limited. Pharmaids Pharmaceuticals Limited is engaged in the manufacturing of ayurvedic medicines and trading of allopathic medicines. The Company operates through the Drug formulations segment. The Company's ayurvedic products include Cofmala, D-LIN, Ayurmax, Cofmala Junior, Ditox, Herbo, Jintan, Pharmalin and D-BO. The Company's allopathic products include A-Flam, Cold CC+Plus, Cold CC, Cold CC SR, Cyclo-plus, Demo, Diclo+plus, Diclo+plus MR, DicloMag+plus, Diclopot, Flox-Top, Icee, Metrex-400, MOL, Nimis+Plus, Nimis, Om-20, Panaroz-40, Probex-T, Proven-Spas, Rider, Rush-Q, Safety-L, Safety, Span-MF, Z-Norm-150 and Z-Norm-300. The Company's manufacturing plant is located at Nalgonda district, Telangana.
Ford US Equity Research covers more than 4,000 stocks using a proprietary quantitative model that evaluates a company’s earnings strength, its relative valuation and recent price movement. Ford’s five recommendation ratings include strong buy, buy, hold, sell, strong sell. For all stocks in our coverage universe, ratings are generated each week and reflect the fundamental and price data as of the last trading day of the week.
Ford Equity International Research Reports cover 60 countries with over 30,000 stocks traded on international exchanges. A proprietary quantitative system compares each company to its peers on proven measures of business value, growth characteristics, and investor behavior. Ford's three recommendation ratings buy, hold and sell, represent each stock’s return potential relative to its own country market.. The rating reports which are generated each week, include the fundamental details behind each recommendation and reflect the fundamental and price data as of the last trading day of the week.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.